1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Quantification of total apolipoprotein e and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
(
- Contribution to journal › Article
- 2017
-
Mark
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
(
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
(
- Contribution to journal › Article
-
Mark
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
(
- Contribution to journal › Article
- 2015
-
Mark
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
(
- Contribution to journal › Article
- 2011
-
Mark
Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
(
- Contribution to journal › Article
- 2010
-
Mark
An enzyme activity as a potential biomarker for Alzheimer's disease.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.497-498(
- Contribution to journal › Published meeting abstract
-
Mark
Convergence of chromogranin and amyloid metabolism in the brain.
2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.511-511(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
(
- Contribution to journal › Article